Amgen Inc

Filings by Amgen Inc span 3 companies, the busiest being Neumora Therapeutics, Inc., BeOne Medicines Ltd. and Vigil Neuroscience, Inc. In total, 4 filings cover trades dated from 10 September 2021 to 19 September 2023.

No open-market sale appears; the market trades are 2 purchases worth €70.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2023 alone, the filings show 1 purchase and no sales.

On 19 September 2023 came the latest disclosure, an open-market purchase for €28.1M in Neumora Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.